| Oct 16 |
Microbot Medical Stock Rises After Completing ACCESS-PVI Trial
|
| Oct 15 |
Microbot eyes FDA application for surgical robot after completing pivotal trial
|
| Oct 15 |
Microbot Medical completes human clinical trial in its ACCESS-PVI
|
| Oct 15 |
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
|
| Sep 30 |
Microbot Medical Says it Expects to Finish its ACCESS-PVI Robotic Surgical System Clinical Trial Ahead of Schedule
|
| Sep 30 |
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
|
| Sep 17 |
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
|
| Aug 29 |
Microbot Medical advances Liberty Robotic System telesurgery innovation
|
| Aug 23 |
Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY
|
| Aug 22 |
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
|
